Licence variation: spironolactone for acne in women

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Contract (Services)
Duration
not specified
Value
___
Sector
HEALTH
Published
17 Jan 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

Yorkshire and the Humber:

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

NHS England required a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.

Award Detail

1 Unnamed (None)
  • Reference: 001753-2025-1

Award Criteria

Quality 60
Social Value 10
Price 30

CPV Codes

  • 85100000 - Health services
  • 85149000 - Pharmacy services

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains